3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Distinct phenotype and function of circulating Vδ1 + and Vδ2 + γδT-cells in acute and chronic hepatitis B

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hepatitis B virus (HBV) persists with global and virus-specific T-cell dysfunction, without T-cell based correlates of outcomes. To determine if γδT-cells are altered in HBV infection relative to clinical status, we examined the frequency, phenotype and function of peripheral blood Vδ1 + and Vδ2 +γδT-cells by multi-parameter cytometry in a clinically diverse North American cohort of chronic hepatitis B (CHB), acute hepatitis B (AHB) and uninfected control subjects. We show that circulating γδT-cells were comprised predominantly of CD3 hiCD4 - Vδ2 +γδT-cells with frequencies that were 2–3 fold higher among Asian than non-Asian Americans and inversely correlated with age, but without differences between CHB, AHB and control subjects. However, compared to control subjects, CHB was associated with increased Tbet hiEomes dim phenotype in Vδ2 +γδT-cells whereas AHB was associated with increased Tbet hiEomes dim phenotype in Vδ1 +γδT-cells, with significant correlations between Tbet/Eomes expression in γδT-cells with their expression of NK and T-cell activation and regulatory markers. As for effector functions, IFNγ/TNF responses to phosphoantigens or PMA/Ionomycin in Vδ2 +γδT-cells were weaker in AHB but preserved in CHB, without significant differences for Vδ1 +γδT-cells. Furthermore, early IFNγ/TNF responses in Vδ2 + γδT-cells to brief PMA/Ionomycin stimulation correlated inversely with serum ALT but not HBV DNA. Accordingly, IFNγ/TNF responses in Vδ2 +γδT-cells were weaker in patients with CHB with hepatitis flare compared to those without hepatitis flares, and this functional deficit persisted beyond clinical resolution of CHB flare. We conclude that circulating γδT-cells show distinct activation and differentiatiation in acute and chronic HBV infection as part of lymphoid stress surveillance with potential role in clinical outcomes.

          Author summary

          We examined circulating γδT-cells in a North American cohort with chronic hepatitis B (CHB) and acute hepatitis B (AHB) compared to uninfected control subjects. While frequencies and composition of circulating γδT-cells were preserved in AHB and CHB, γδT-cells showed distinct and innate phenotypes based on the expression of Tbet/Eomes in association with various NK/T-cell markers. Notably, IFNγ/TNF responses to phosphoantigens and PMA/Ionomycin were preserved in CHB, but weaker in AHB compared to uninfected control subjects, in association with NKG2A/CD94 but not PD1. Furthermore, early IFNγ/TNF responses in Vδ2 + γδT-cells to brief PMA/Ionomycin stimulation showed significant inverse correlations with serum alanine aminotransferase, a measure of hepatocellular injury, and were persistently deficient in CHB subjects with hepatitis flare compared to those without such flares. Finally, Vδ2 + γδT-cells were significantly enriched for Tbet hiEomes dim phenotype in associations with their expression of NK and T-cell activation and regulatory markers, suggesting a role for Tbet in γδT-cell differentiation and function. We conclude that circulating γδT-cells show distinct activation and differentiation in acute and chronic HBV infection as part of lymphoid stress surveillance with potential role in clinical outcomes.

          Related collections

          Most cited references65

          • Record: found
          • Abstract: not found
          • Article: not found

          Chronic hepatitis B.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            γδ T cells in cancer.

            With the promise of T cell-based therapy for cancer finally becoming reality, this Review focuses on the less-studied γδ T cell lineage and its diverse responses to tumours. γδ T cells have well-established protective roles in cancer, largely on the basis of their potent cytotoxicity and interferon-γ production. Besides this, recent studies have revealed a series of tumour-promoting functions that are linked to interleukin-17-producing γδ T cells. Here, we integrate the current knowledge from both human and mouse studies to highlight the potential of γδ T cell modulation to improve cancer immunotherapy.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              γδ T cells: first line of defense and beyond.

              γδ T cells, αβ T cells, and B cells are present together in all but the most primitive vertebrates, suggesting that each population contributes to host immune competence uniquely and that all three are necessary for maintaining immune competence. Functional and molecular analyses indicate that in infections, γδ T cells respond earlier than αβ T cells do and that they emerge late after pathogen numbers start to decline. Thus, these cells may be involved in both establishing and regulating the inflammatory response. Moreover, γδ T cells and αβ T cells are clearly distinct in their antigen recognition and activation requirements as well as in the development of their antigen-specific repertoire and effector function. These aspects allow γδ T cells to occupy unique temporal and functional niches in host immune defense. We review these and other advances in γδ T cell biology in the context of their being the major initial IL-17 producers in acute infection.
                Bookmark

                Author and article information

                Contributors
                Role: ConceptualizationRole: Data curationRole: Formal analysisRole: Funding acquisitionRole: InvestigationRole: MethodologyRole: Project administrationRole: ResourcesRole: SupervisionRole: ValidationRole: VisualizationRole: Writing – original draftRole: Writing – review & editing
                Role: Data curationRole: Formal analysisRole: InvestigationRole: MethodologyRole: Validation
                Role: ConceptualizationRole: Formal analysisRole: InvestigationRole: MethodologyRole: ValidationRole: Visualization
                Role: Data curationRole: Formal analysisRole: InvestigationRole: Methodology
                Role: Formal analysisRole: InvestigationRole: MethodologyRole: Validation
                Role: InvestigationRole: ResourcesRole: Writing – review & editing
                Role: Formal analysisRole: MethodologyRole: Writing – review & editing
                Role: ResourcesRole: Writing – review & editing
                Role: InvestigationRole: ResourcesRole: Writing – review & editing
                Role: InvestigationRole: ResourcesRole: Writing – review & editing
                Role: ResourcesRole: Writing – review & editing
                Role: ResourcesRole: Writing – review & editing
                Role: InvestigationRole: ResourcesRole: Writing – review & editing
                Role: ResourcesRole: Writing – review & editing
                Role: Formal analysisRole: Investigation
                Role: ResourcesRole: Writing – review & editing
                Role: Formal analysisRole: MethodologyRole: Writing – review & editing
                Role: ConceptualizationRole: InvestigationRole: Writing – review & editing
                Role: InvestigationRole: ResourcesRole: SupervisionRole: Writing – review & editing
                Role: Editor
                Journal
                PLoS Pathog
                PLoS Pathog
                plos
                plospath
                PLoS Pathogens
                Public Library of Science (San Francisco, CA USA )
                1553-7366
                1553-7374
                18 April 2019
                April 2019
                : 15
                : 4
                : e1007715
                Affiliations
                [1 ] Medical Research, The Corporal Michael J. Crescenz VA Medical Center, Philadelphia PA, United States of America
                [2 ] Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia PA, United States of America
                [3 ] Toronto Centre for Liver Disease, University of Toronto, Toronto, Ontario, Canada
                [4 ] University of Pittsburgh Graduate School of Public Health, Pittsburgh PA, United States of America
                [5 ] Department of Medicine, University of California, San Francisco, San Francisco CA, United States of America
                [6 ] Department of Internal Medicine, Virginia Commonwealth University, Richmond VA, United States of America
                [7 ] Harborview Medical Center, University of Washington Medical Center, Seattle WA, United States of America
                [8 ] Department of Medicine, Beth Israel Deaconess Medical Center, Boston MA, United States of America
                [9 ] Department of Internal Medicine, Mayo Clinic, Rochester MN, United States of America
                [10 ] Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas TX, United States of America
                [11 ] Department of Internal Medicine, University of Michigan, Ann Arbor MI, United States of America
                Nationwide Children's Hospital, UNITED STATES
                Author notes

                Anna S. F. Lok has received research grants (to the University of Michigan) from Bristol-Myers Squibb and Gilead, and has served on advisory board of Gilead.

                ¶ Membership of the Hepatitis B Research Network (HBRN) is listed in the Acknowledgments.

                Author information
                http://orcid.org/0000-0001-6811-9364
                http://orcid.org/0000-0002-0195-5525
                http://orcid.org/0000-0002-3310-3538
                http://orcid.org/0000-0001-9178-9139
                http://orcid.org/0000-0001-7885-8574
                http://orcid.org/0000-0001-7931-494X
                Article
                PPATHOGENS-D-18-01661
                10.1371/journal.ppat.1007715
                6490945
                30998783
                6a35321c-96ed-4b10-a549-fb0f26bc86e2

                This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

                History
                : 25 August 2018
                : 19 March 2019
                Page count
                Figures: 9, Tables: 1, Pages: 35
                Funding
                Funded by: funder-id http://dx.doi.org/10.13039/100000002, National Institutes of Health;
                Award ID: UO-1DK082866
                Funded by: funder-id http://dx.doi.org/10.13039/100000060, National Institute of Allergy and Infectious Diseases;
                Award ID: R01-AI-47519
                Funded by: funder-id http://dx.doi.org/10.13039/100000002, National Institutes of Health;
                Award ID: P30DK5036
                Funded by: funder-id http://dx.doi.org/10.13039/100000002, National Institutes of Health;
                Award ID: M01-RR00040
                Funded by: funder-id http://dx.doi.org/10.13039/100000062, National Institute of Diabetes and Digestive and Kidney Diseases;
                Award ID: DK 082043
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/100000062, National Institute of Diabetes and Digestive and Kidney Diseases;
                Award ID: DK082863
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/100000062, National Institute of Diabetes and Digestive and Kidney Diseases;
                Award ID: DK082866
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/100000062, National Institute of Diabetes and Digestive and Kidney Diseases;
                Award ID: DK082874
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/100000062, National Institute of Diabetes and Digestive and Kidney Diseases;
                Award ID: U01 DK 082872
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/100000062, National Institute of Diabetes and Digestive and Kidney Diseases;
                Award ID: DK082919
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/100000062, National Institute of Diabetes and Digestive and Kidney Diseases;
                Award ID: DK082923
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/100000062, National Institute of Diabetes and Digestive and Kidney Diseases;
                Award ID: U01 DK082944
                Award Recipient :
                Funded by: NIH/NIDDK Center of Molecular Studies in Digestive and Liver Diseases
                Award ID: P30DK50306
                Award Recipient :
                Funded by: NIH Public Health Service Research Grant
                Award ID: M01-RR00040
                Award Recipient :
                Funded by: VA Merit Review
                Award ID: BX000649
                Award Recipient :
                Funded by: NCATS (National Center for Advancing Translational Sciences, NIH
                Award ID: UL1TR000058
                Award Recipient :
                Funded by: CTSA
                Award ID: UL1TR000004
                Award Recipient :
                Funded by: CTSA
                Award ID: UL1TR00224002
                Award Recipient :
                Funded by: Gilead Sciences, Inc.
                Award ID: CRADA through the NIDDK
                Funded by: Roche Molecular Systems
                Award ID: CRADA through the NIDDK
                Funded by: An interagency agreement with NIDDK Lilia M. Ganova-Raeva, PhD.
                Award ID: A-DK-3002-001
                Funded by: Support from the intramural program, NIDDK, NIH Marc G. Ghany, MD
                Funded by: funder-id http://dx.doi.org/10.13039/100006379, Office of Research and Development;
                Funded by: Department of Veterans Affairs
                Funded by: Corporal Michael J. Crescenz VA Medical Center in Philadelphia
                Funded by: The Philadelphia Corporal Michael J. Crescenz VA Medical Research
                Funded by: funder-id http://dx.doi.org/10.13039/100000062, National Institute of Diabetes and Digestive and Kidney Diseases;
                Award ID: DK082864
                Funded by: funder-id http://dx.doi.org/10.13039/100000062, National Institute of Diabetes and Digestive and Kidney Diseases;
                Award ID: DK082867
                Funded by: funder-id http://dx.doi.org/10.13039/100000062, National Institute of Diabetes and Digestive and Kidney Diseases;
                Award ID: DK082871
                Funded by: funder-id http://dx.doi.org/10.13039/100000062, National Institute of Diabetes and Digestive and Kidney Diseases;
                Award ID: DK082927
                Funded by: funder-id http://dx.doi.org/10.13039/100000062, National Institute of Diabetes and Digestive and Kidney Diseases;
                Award ID: DK082943
                This study was supported by NIH Grants UO-1DK082866 and R01-AI-47519; the Philadelphia Corporal Michael J. Crescenz VA Medical Research; NIH/NIDDK Center of Molecular Studies in Digestive and Liver Diseases P30DK50306 and its Molecular Biology and Cell Culture Core Facilities; the NIH Public Health Service Research Grant M01-RR00040. This material is based upon work supported in part by the Office of Research and Development, Department of Veterans Affairs and with the resources and the use of facilities at the Corporal Michael J. Crescenz VA Medical Center in Philadelphia. The contents of this work do not represent the views of the Department of Veterans Affairs or the United States Government. Funding for HBRN: The HBRN was funded by a U01 grant from the National Institute of Diabetes and Digestive and Kidney Diseases to the following investigators Lewis R. Roberts, MB, ChB, PhD (DK 082843), Anna Suk-Fong Lok, MD (DK082863), Steven H. Belle, PhD, MScHyg (DK082864), Kyong-Mi Chang, MD (DK082866), Michael W. Fried, MD (DK082867), Adrian M. Di Bisceglie, MD (DK082871), William M. Lee, MD (U01 DK082872), Harry L. A. Janssen, MD, PhD (DK082874), Daryl T-Y Lau, MD, MPH (DK082919), Richard K. Sterling, MD, MSc (DK082923), Steven-Huy B. Han, MD (DK082927), Robert C. Carithers, MD (DK082943), Norah A. Terrault, MD, MPH (U01 DK082944), an interagency agreement with NIDDK: Lilia M. Ganova-Raeva, PhD (A-DK-3002-001) and support from the intramural program, NIDDK, NIH: Marc G. Ghany, MD. Additional funding to support this study was provided to Kyong-Mi Chang, MD, the Immunology Center, (NIH/NIDDK Center of Molecular Studies in Digestive and Liver Diseases P30DK50306, NIH Public Health Service Research Grant M01-RR00040, VA Merit Review BX000649), Richard K. Sterling, MD, MSc (UL1TR000058, NCATS (National Center for Advancing Translational Sciences, NIH), Norah A. Terrault, MD, MPH (CTSA Grant Number UL1TR000004), Mandana Khalili (K24AA022523), Michael W. Fried, MD (CTSA Grant Number UL1TR001111), and Anna Suk-Fong Lok (CTSA Grant Number UL1TR00224002.) Additional support was provided by Gilead Sciences, Inc. and Roche Molecular Systems via a CRADA through the NIDDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, some of the NIH/NIDDK scientists participated in the HBRN Steering Committee and Executive Committee involved in decision making for the overall study that impacted this immunology study and publication.
                Categories
                Research Article
                Custom metadata
                vor-update-to-uncorrected-proof
                2019-04-30
                All data are contained within the manuscript and its supporting information files.

                Infectious disease & Microbiology
                Infectious disease & Microbiology

                Comments

                Comment on this article